Ghost Tree Capital’s Bristol-Myers Squibb BMY Stock Holding History

Ghost Tree Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-75,000	Closed	-$4.69M	–	53
2017 Q3	$4.78M	Buy	+75,000	New	+$4.38M	1.02%	36
2017 Q1	–	Sell	-100,000	Closed	-$5.48M	–	73
2016 Q4	$5.84M	Buy	+100,000	New	+$5.47M	1.41%	31
2014 Q2	–	Sell	-80,000	Closed	-$4.16M	–	60
2014 Q1	$4.16M	Sell	80,000 -20,000	-20%	-$1.06M	2.47%	10
2013 Q4	$5.32M	Buy	+100,000	New	+$5.09M	3.27%	7

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ghost Tree Capital's BMY Position: Q4 2017 in Review

Ghost Tree Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 75,000 shares — an estimated $4.69M sold.

Ghost Tree Capital first reported a position in BMY in Q4 2013 and held it in 4 quarters. The position peaked at $5.84M in Q4 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Ghost Tree Capital reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
Ghost Tree Capital sold 75,000 Bristol-Myers Squibb shares in Q4 2017, an estimated $4.69M.
Ghost Tree Capital first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 4 quarters.
Ghost Tree Capital's Bristol-Myers Squibb position peaked at $5.84M in Q4 2016.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Ghost Tree Capital's 13F filing for Q4 2017, filed 14 Feb 2018.